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Abstract
Background: The identification of novel genes by high-throughput studies of complex diseases is
complicated by the large number of potential genes. However, since disease-associated genes tend
to interact, one solution is to arrange them in modules based on co-expression data and known
gene interactions. The hypothesis of this study was that such a module could be a) found and
validated in allergic disease and b) used to find and validate one ore more novel disease-associated
genes.
Results: To test these hypotheses integrated analysis of a large number of gene expression
microarray experiments from different forms of allergy was performed. This led to the
identification of an experimentally validated reference gene that was used to construct a module of
co-expressed and interacting genes. This module was validated in an independent material, by
replicating the expression changes in allergen-challenged CD4+ cells. Moreover, the changes were
reversed following treatment with corticosteroids. The module contained several novel diseaseassociated genes, of which the one with the highest number of interactions with known disease
genes, IL7R, was selected for further validation. The expression levels of IL7R in allergen challenged
CD4+ cells decreased following challenge but increased after treatment. This suggested an
inhibitory role, which was confirmed by functional studies.
Conclusion: We propose that a module-based analytical strategy is generally applicable to find
novel genes in complex diseases.
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Background
Most common diseases, including allergy and diabetes,
are complex. The genetic susceptibility of an individual to
such a disease appears not to be the result of a single causative gene but rather arises from multiple interacting
genes. The identification of novel disease-associated genes
is complicated not only by the large number of potentially
relevant genes as well as the heterogeneity of the diseases.
One approach to address this complexity is to arrange disease-associated genes in networks, where the genes form
nodes and the interactions between the genes are represented by links between the nodes. Since disease genes
tend to interact [1,2] the investigation may be facilitated
by searching for sub-networks of co-expressed and interacting genes (such sub-networks will henceforth be
referred to as modules). The rationale behind this is that
in gene interaction networks, functionally related genes
tend to form modules of tightly interacting genes [1,2].
Thus, such modules give an overview of the main disease
mechanisms and could thus be dissected to find novel
genes [3,4]. It is not known if such a module-based analysis is generally applicable to complex diseases that are
caused by altered interactions between many different cell
types and tissues. The hypothesis of this study was that
such a module could be a) found and validated in allergic
disease and b) used to find and validate one or more
novel disease-associated genes (i.e. genes that either show
disease-associated changes in expression or whose alleles
influence the risk of disease). Allergy was chosen as a
model of complex diseases because the main disease process is known and readily examined in both clinical and
experimental studies; an allergen causes increased release
of cytokines from type 2 T helper (Th2) cells which activate B cells, eosinophils and mast cells to release inflammatory proteins [5]. This disease process is thought to be
common to different forms of allergy, such as seasonal
allergic rhinitis (SAR), atopic eczema and asthma. It
involves many well-documented genes that can be used as
references to validate the bioinformatic analyses as well as
to construct modules of co-expressed and interacting
genes. Moreover, since disease genes tend to interact,
interactions with known disease genes can be used as a criterion to select novel genes for functional validation.
However, several observations indicate more complex disease mechanisms than implied by the Th2 induced disease process. Many other cell types and tissues have been
implicated and genomic high-throughout studies have
shown the involvement of hundreds of genes. Several of
these genes do not appear to overlap in different forms of
allergy or to have roles that can be explained by the Th2
paradigm [6-11].
Based on the underlying principle that disease-associated
genes tend to interact, we first identified a gene with a key
regulatory role for the disease. This was used as a reference
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gene to construct a module and then dissected that to find
the novel gene that had most interactions with known disease-associated genes. This was achieved by combining
integrated analysis of gene expression microarray data
with experimental studies.
We propose that these module-based analytical principles
may be generally applicable to find novel genes in complex diseases.

Results
The hypothesis of this study has been that a module of
disease-associated genes could be found and validated in
allergic disease, and then used to find and validate one or
more novel disease genes. A step-wise analytical approach
was employed (figure 1):
First, a gene with key regulatory role for the disease was
identified based on converging data from integrated analysis of gene expression microarray data from allergic
patients and healthy controls, information in the literature and experimental validation studies. Next, this gene
was used to build a hypothetical module of genes co-regulated by the same transcription factors (TFs). The underlying assumption was that functionally related genes, such
as those in a pathway or a module, are often co-regulated
by the same TFs. The TFs and their target genes were identified and organized into a module by combining comparative promoter analysis, gene expression data and
known gene interactions. This hypothetical module was
tested in an independent material, by examining if the
expression changes of the module genes could be replicated. Finally, the module was searched for a novel disease
gene that was validated by functional studies.
1) Identification of disease-associated genes by integrated
analysis of gene expression microarray data from cells and
tissues from patients with different forms of allergy and
healthy controls
Combinatorial algorithms were used to extract groups of
highly inter-connected genes (cliques) from graphs
derived from transcriptomal correlation matrices containing millions of correlate pairs [12-14]. This resulted in the
identification of 103 genes that will henceforth be referred
to as disease-associated genes.
2) Identification of a common pathway among the diseaseassociated genes
A manually curated pathway database (Ingenuity Pathway
Analysis, IPA) was used to identify pathways among the
disease-associated genes (see additional figure 1). IPA is a
bioinformatics program that is based on manual review of
more than 200,000 scientific publications. The resulting
network of direct physical, transcriptional, and enzymatic
interactions between mammalian orthologues was used
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as a template to organize the disease-associated genes into
statistically scored pathways. The pathway that received
the highest statistical score was T cell receptor (TCR) signaling (p < 10-6), which included genes belonging to the
TCR complex (TCRA, TCRB, CD3Z and CD3D) as well as
down-stream genes, ZAP70, LAT, LCK and ITK. In addition, the remaining disease-associated genes were
searched for genes that had direct interactions with those
generated by the pathway database. Three other diseaseassociated genes fulfilled this criterion, namely IKBKG
[15], LEF1 [16], and MAP4K1 [17]. The above mentioned
genes will henceforth be referred to as TCR pathway genes.

CD4+ cells

Transcription factor (GATA3)
(5) Hypothetical module of GATA3 regulated genes

Gene expression

(6) Expression profiling to validate the hypothetical module

CD4+ cells

(7) Topological analysis to find a novel gene (IL7R)

Figure
An
outline
1 of the analytical process in the study
An outline of the analytical process in the study. 1)
Integrated analysis of gene expression microarrays to find
disease-associated genes, 2) Bioinformatic identification of a
key pathway among those genes 3) Selection and experimental validation of a reference gene in the pathway, 4) Combined comparative promoter and gene expression
microarray analysis to find a transcription factor that co-regulated the reference genes and other putative module genes,
5) Construction of a hypothetical module based on genes coregulated by the transcription factor, 6) Independent gene
expression microarray studies to validate the hypothetical
module, 7) Topological analysis of module genes to find a
novel gene. Experimental validation of the gene.

3) Identification and experimental validation of a
reference gene in the TCR pathway
This step aimed to find a reference gene in the TCR pathway that in the next step would be used to build a hypothetical module of functionally related disease genes. We
proceeded by examining the TCR pathway in allergenchallenged CD4+ cells from patients with seasonal allergic
rhinitis (SAR). Gene expression microarray analyses of
these cells showed a more than a two-fold increase in
expression of six of the TCR pathway genes; CD3D, CD3Z,
LCK, ITK, ZAP70 and MAP4K1. Of these, ITK was selected
as a putative reference gene because of its involvement in
the polarization of Th2 cells and its location in a chromosomal susceptibility region for allergy, 5q31-33 [18]. The
functional role of ITK was explored in an in vivo mouse
model of allergic inflammation in the upper and lower
airways. Allergen challenge resulted in a marked goblet
cell hyperplasia in bronchi and bronchioles (figure 2A).
This response was significantly reduced in similarly
treated ITK-/- animals. In both upper and lower airways the
allergen exposure led to eosinophilia that was significantly reduced in ITK-/- mice (figure 2B).
4) Identification of transcription factors that regulated
ITK
Functionally related genes, such as those in a pathway or
a module, are often co-regulated by the same transcription
factors (TFs). Thus, if the TF that regulated ITK and other
genes of the TCR pathway could be identified this information could be used to find other disease-associated
genes and organize them into a hypothetical disease module. Comparative promoter analysis revealed a framework
of TF binding sites that was shared by ITK and two other
TCR pathway genes, CD3D and LEF1 (see additional file 1
for details). The framework contained TFBS for TF of the
GATA, MYB and MYT1 families (figure 3). Gene expression microarray analysis showed that the corresponding
TF, namely GATA3, MYB and MYBL1 increased in allergen-challenged CD4+ cells (7-, 9- and 3-fold increases,
respectively). To filter out the TF that was most relevant
for Th2 polarization we analysed their correlations with
ITK in gene expression microarray data from CD4+ cells
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The manifestation of an allergic inflammation is significantly reduced in mice lacking ITK. Numbers of
PAS-positive bronchial goblet cells (A). EPO-histochemistry
was used to quantify the tissue eosinophilia in the upper airways, bronchi, and around large pulmonary vessels (B). Data
are presented as means ± SEM. Stars denote levels of statistical difference between OVA-treated wild-type and ITK-deficient animals (* = P < 0.05, ** = P < 0.01, *** = P < 0.001).

from 73 atopic patients and 19 non-atopic controls. The
correlations between ITK to GATA3, MYB and MYBL1
were r = 0.68 (p < 0.0001), 0.41 (p < 0.001) and 0.25 (p
< 0.01), respectively. Because GATA3 had the highest correlation coefficient it was chosen to construct a hypothetical module as described below.
5) Construction of a hypothetical module of genes coregulated by GATA3
Since functionally related genes are often co-regulated by
the same TF, we used GATA3 to construct a hypothetical
module. We started by identifying 47 genes previously
described to interact with GATA3. To filter out those of the
interacting genes that were relevant for human CD4+ cells
we again analyzed the gene expression microarray data
from the CD4+ cells from the 73 atopic patients and 19
non-atopic controls. Genes whose expression values correlated with GATA3 (r > 0.4 and p < 0.0001) were considered as hypothetical module genes. This resulted in a
module that comprised 37 genes, several of which had key

Figure 3 of three transcription factor binding sites
Framework
Framework of three transcription factor binding
sites. The parameters and their abbreviations are: +, sense
strand orientation; -, anti-sense strand orientation; cs, minimal core similarity; ms, minimal matrix similarity. Generally,
cs was at default (0.75) and ms thresholds were the optimised default values for the respective matrices; distance,
number of nucleotides to the next element (arrows in the
upper part of the figure). GATA; strand, +; distance to next
element, 8–74 bp. MYBL; strand, +; distance to next element,
63–100 bp. MYT1; strand, -.

roles in allergic disease, for example IFNG and IL4R (table
1).
6) Validation of the hypothetical module
To validate the module we hypothesized that the module
genes would show significant gene expression changes in
an independent material of allergen-challenged CD4+
cells from 19 patients with SAR. Indeed, out of 33 genes
that had detectable levels, 23 did change significantly.
These genes formed a tightly connected module with an
average of 3 ± 1 interactions/gene (figure 4). Since glucocorticoids are effective in treating allergic inflammation
we hypothesized that this treatment would significantly
reverse the expression levels of the 23 module genes.
Indeed, 16 of the 23 genes satisfied this hypothesis.
7) Identification and validation of a novel disease gene in
the module
Eleven of the 23 module genes that had been validated by
the independent gene expression microarray study (figure
4) had not been previously been described in allergic diseases. These were EED, ESR1, GRPR44, HSDP1, IL7R,
LEF1, MAF, PTPRJ, RUNX3, TCF12, and SH2D1A. Since
disease-associated genes tend to interact [1,2] we computed the number of interactions between each of these
eleven genes and the remaining, known disease-associated genes. The average number of interactions was 2.6 ±
0.4. IL7R had the highest number of interactions (n = 5)
that included signature genes for Th2 activation like IL4R
and IFNG. The expression levels of IL7R were lower in
allergen-challenged CD4+ cells compared to diluent-
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Table 1: Genes included in the hypothetical module

Gene symbol

Gene Name

CCR4
CD28
CD3D
CFLAR
CTLA4
EDG1
EED
ESR1
GATA2
GATA3
GPR44
HIVEP2
HSPD1
IFNG
IL4R
IL6
IL7
IL7R
IRF4
IRS1
ITK
LEF1
LTA
LTB
MAF
MAPK1
NFKB1
NPPA
PP3CA
PTCRA
PTPRJ
RUNX3
SH2D1A
STAT4
TCF12
TCF3
TNF

Chemokine (C-C motif) receptor 4
Antigen CD28
CD3 Antigen, delta subunit
CASP8- and fadd-like apoptosis regulator
Cytotoxic t lymphocyte-associated 4
Endothelial differentiation gene 1
Embryonic ectoderm development protein
Estrogen receptor 1
GATA-binding protein 2
GATA binding protein 3
G protein-coupled receptor 44
HUMAN immunodeficiency virus type 1 enhancer-binding protein 2
Heat-shock 60-kd protein 1
Interferon, gamma
Interleukin 4 receptor
Interleukin 6
interleukin 7
interleukin 7 receptor
Interferon regulatory factor 4
Insulin receptor substrate 1
IL2-inducible T-cell kinase
Lymphoid enhancer-binding factor 1
Lymphotoxin-alpha
Lymphotoxin-beta
V-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog
Mitogen-activated protein kinase 1
Nuclear factor kappa-b, subunit 1
Natriuretic peptide precursor A
Protein Phosphatase 3 catalytic subunit, alpha isoform
Pre-t-cell receptor, alpha-chain precursor
Protein-tyrosine phosphatase, receptor-type, J
Runt-related transcription factor 3
SH2 domain protein 1A
Signal transducer and activator of transcription 4
Transcription factor 12
Transcription factor 3
Tumor necrosis factor

treated cells from patients, while treatment with corticosteroids increased the expression of IL7R (figure 5, both p
< 0.001). Gene expression microarray analysis of an independent material of allergen-challenged CD4+ cells from
patients and healthy controls, also showed lower expression in patients, 3724 ± 512 vs. 5090 ± 519 (p = 0.003).
These findings suggested the hypothesis that IL-7R signaling would inhibit the activation of Th2 cells. To test this
hypothesis we examined if IL-7 would decrease production of the Th2 cytokine IL-4 from allergen-challenged
PBMCs from allergic patients. However, IL-7 stimulation
had the opposite effect; a 3-fold increased production of
IL-4, 1.10 ± 0.45 compared to 3.22 ± 1.73 pg/mL, p < 0.05
(figure 6A). Similarly, the Th2 cytokines IL-5 and IL-13
also increased following IL-7 stimulation (see additional
file 1). This suggested an alternative hypothesis, namely
that IL-7R signaling also activated Th1 cells, but to a

higher degree than that of Th2 cells, thereby causing a
shift in the balance between Th1/Th2 cells towards a Th1
polarization. Indeed, IL-7 treatment caused a 7-fold
increase of IFN-γ, 37 ± 13 compared to 253 ± 133 pg/mL,
p < 0.05 (figure 6B). To measure the effect of IL-7 on the
Th1/Th2 balance the ratio between IL-4/IFN-γ-3 was computed; this ratio decreased significantly in allergen-challenged CD4+ cells that were treated with IL-7 compared to
untreated cells, 30 compared to 15, p < 0.05 (figure 6C).
Thus, by a relatively higher Th1 than Th2 stimulation IL-7
signaling had a Th1 polarizing effect, which is consistent
with an inhibitory role of IL-7R in allergic inflammation.

Discussion
Identification of novel genes in high-throughput studies
of complex diseases may require choosing between hundreds of genes. Since disease genes tend to interact with
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with seasonal
Figure
4 representation
allergic rhinitis
Network
of module formed by genes co-regulated by GATA3 in allergen-challenged CD4+ cells from patients
Network representation of module formed by genes co-regulated by GATA3 in allergen-challenged CD4+ cells
from patients with seasonal allergic rhinitis. The interaction network was generated using Ingenuity pathway analysis.
Genes shaded in red were up-regulated whereas green were down-regulated. The color intensity reflects the significance value
of the regulation. Solid and dotted lines represent direct and indirect interactions, respectively. Node shapes represent the
class of molecule, for example donut shapes represent transcription factors (for detailed information see, http://www.ingenuity.com)

each other [1,2] the choice may be facilitated by searching
for modules of disease genes that are co-expressed and
interact [3,4].
It is not known if the module-based analytical strategy can
also be applied to complex diseases other than cancer,
which result from altered interactions between multiple
cells and tissues. The hypothesis in this study was that we
could find and validate a disease module in allergic disease and use this to find a novel disease gene.

In a recent study of breast cancer four known disease
genes were used as references to construct a module of disease genes [3]. However, since allergy involves many different cells and tissues such an approach would result in a
large number of reference genes to prioritize between. We
therefore first performed an integrated analysis of gene
expression microarray data from different forms of allergic diseases to find a common pathway. That pathway was
used to find a reference gene for module construction. T
cell receptor (TCR) signaling was the pathway with the
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and validated a transcription factor (TF) that was shared
by ITK and two other TCR pathway genes. This TF, GATA3,
was used to construct a hypothetical module based on
known gene interactions and co-expression data. This
module contained a set of genes involved not only in TCR
signaling, but also Th2 cell differentiation and homing.
However, rather than being organized in distinct pathways these genes were highly interconnected. This suggests that complex cellular behavior like Th2 cell homing
and activation is based on the co-regulation of genes from
different pathways by common TF such as GATA3.
Validation studies showed that the module could be replicated in an independent material. Moreover, since corticosteroids are effective in treating allergic disease we
tested if this treatment would also reverse the expression
levels of the genes that had changed after allergen-challenge. Indeed, this was true for a significant proportion of
the module genes. Taken together these findings lent
strong support for our hypothesis that a relevant module
could be found and validated in allergic disease.
We also hypothesized that the module could be used to
identify a novel disease gene. Indeed, eleven of the 23
module genes had not been previously described in
allergy, but may have important roles. For example,
SH2D1A that promotes Th2 activation [20] increased in
expression following allergen-challenge. However, while
there are several options for functional studies of individual genes, it is less clear how to select one for such studies.
Recent work indicates that genes with many interactions
are functionally more important than those with few
interactions [1,2]. We therefore reasoned that since disease genes tend to interact the novel gene that had most
interactions with known disease genes would be most
likely to be pathogenic. Analysis of the connectivity of the
novel genes led to the identification of IL7R, whose relevance was supported by converging observations; IL7R's
interactions included two signature genes for Th1 and Th2
activation, namely IFNG and IL4R [21]; the expression
levels of IL7R showed highly significant decreases in the
allergen-challenged CD4+ cells which were reversed by
treatment with corticosteroids. Such expression changes
are characteristic for genes that inhibit allergic inflammation [22,23]. These observations led to the hypothesis that
IL7R inhibited Th2 cell activation. To test this hypothesis
we treated allergen-challenged cells with IL-7. However,
this resulted in increased rather than decreased IL-4 production, indicating that IL-7 activated Th2 cells. We therefore hypothesized that IL-7 stimulation would result in a
relatively stronger activation of Th1 than Th2 cells.
Indeed, IL-7 did cause an increased production of the Th1
cytokine IFN-γ, which significantly decreased the ratio
between IL-4/IFN-γ. Thus, by inducing a relatively higher
Th1 than Th2 activation, IL-7 signaling has a Th1 like

http://www.biomedcentral.com/1752-0509/3/19

effect, which is consistent with an inhibitory role of IL-7R
in allergic inflammation. This has not been previously
described, but increased expression of IL7R has been
shown in Th1-like disorders like multiple sclerosis [24].
This suggests that this gene may have therapeutic potential in inflammatory diseases that depend on an altered
balance between Th1 and Th2 cells.
The identification of IL7R in this study also supports the
second hypothesis, namely that a module-based approach
can be applied to find novel genes. It is also of note that
although there is limited information about gene interactions, analyzing the number of interactions with known
disease genes is a useful complementary method to prioritize between novel module genes for validation studies.

Conclusion
The identification of novel genes by high-throughput
studies of complex diseases is complicated by the large
number of potential genes. Since disease genes tend to
interact, one solution is to arrange them in modules based
on co-expression data and known gene interactions. In
this study we validated the hypothesis that such a module
could be a) found and validated in allergic disease and b)
used to find and validate one ore more novel disease
genes. We propose that the analytical principles may be
generally applicable to complex diseases.

Methods
Subjects analyzed with DNA microarrays
For the integrated analysis a total of 36 patient samples
were analyzed with 40 DNA microarrays. A total of 27
control samples were analyzed with 31 DNA microarrays.
These samples were used for steps 1–3 in the results. In
addition, for step 4, coexpression studies were performed
in T helper cells from 73 atopic patients and 19 nonatopic controls. These materials have been described in
detail elsewhere [7-9,25]. The validation studies of hypothetical module genes in steps 5–7 were performed in
CD4+ cells from 19 patients, a) with and b) without allergen-challenge as well as c) with challenge and treatment
with cortisone. Samples from each individual were analyzed with one microarray, unless otherwise stated. All
gene expression microarray data, except those from the
asthmatic patients, are derived from studies performed by
the authors of this study. The materials can be summarized as follows:
Seasonal allergic rhinitis (SAR)
1) CD4+ T cells from 22 patients with SAR were examined
before and after stimulation with grass pollen extract.
CD4+ T cells will subsequently referred to as T helper cells.
The cells were obtained outside of the pollen season. 2)
Nasal fluid cells from 18 patients before the pollen season
sampled before allergen challenge as well as one and six
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hours after allergen challenge. In addition nasal fluid cells
were obtained from symptomatic patients during season.
The nasal fluid cells from each time point were pooled
and analyzed with one DNA microarray GeneChip at each
time point. 3) Skin biopsies from ten patients sampled
one hour after subcutaneous allergen challenge 4) Nasal
polyps from two patients with SAR analyzed before and
after treatment with glucocorticoids. Each polyp was analyzed with duplicate microarrays on each occasion.

22,283 genes and variants (HuGe U133A GeneChip,
Affymetrix, Santa Clara, CA) as previously described [2].
The validation studies of allergen-challenged CD4+ cells
from patients with SAR were performed DNA microarrays
measuring the expression of 47293 genes (Illumina, San
Diego, CA). The analyses were performed according to
manufacturer's instructions and the MIAME guidelines.
Identification of disease-associated genes was performed
as described in the additional file 1.

Asthma
T helper cells from seven patients with mild asthma and
five patients with severe asthma.

Network-based analysis of disease-associated genes
The Ingenuity Pathways Analysis application (IPA) was
used to organize the disease-associated genes into networks of interaction and to find modules of functionally
related genes that correspond to pathways as previously
described [7]. A detailed description is given in the additional file 1.

Eczema
Skin biopsies from ten patients with atopic eczema who
fulfilled the criteria of Williams.
Controls
1) T helper cells from four healthy controls. 2) Nasal fluid
cells from twenty healthy controls. The nasal fluid cells
were pooled and analyzed with one DNA microarray
GeneChip. 3) Nasal polyps from two patients without
allergy, before and after treatment with glucocorticoids.
Each sample was analyzed with duplicate DNA microarrays. 4) Skin biopsies from ten healthy controls. 5) Allergen-challenged skin biopsies from ten healthy controls
(these individuals were not the same as in study 4). The
raw array data are available at Gene Expression Omnibus
http://www.ncbi.nlm.nih.gov/geo, pending processing,
accession numbers GSE6012, GDS266 and GSE473.
Allergen challenge of peripheral blood mononuclear cells
Peripheral blood mononuclear cells were prepared and
stimulated with grass pollen extract with or without
hydrocortisone as described [7]. For gene expression studies, T helper cells were enriched from the allergen-challenged PBMC using anti-CD4-coated paramagnetic
microbeads and a MACS (magnetic cell sorter) system
according to the instructions of the manufacturer
(Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
cRNA was extracted from 200 ng total RNA using
Ambion's Illumina RNA TotalPrep Amplification kit
(Ambion, Inc., U.S.A.). In vitro transcription (IVT) reaction and cRNA biotinylation was performed overnight (14
h). The RNA/cRNA concentrations where checked using
Nanodrop ND-1000 before and after the amplifications.
cRNA quality was controlled by BioRad's Experion electrophoresis station (Bio-Rad Laboratories, Inc., CA,
U.S.A.).
Microarray hybridization and data analysis
All gene expression profiling studies except the validation
data in allergen-challenged CD4+ cells were performed
using DNA microarrays measuring the expression of

Identification of a shared framework of transcription
factor binding sites for the T cell receptor pathway
A shared framework of transcription factor binding sites
(TFBS) for genes of the T cell receptor pathway was identified using a set of in silico genomics tools (see additional
file 1).
Animal Experiments
An exploration of ITK-deficient mice in a validated mouse
model of allergic airway inflammation was used to assess
the involvement of ITK in manifesting characteristic pathogenic features of an allergic inflammation. Tissue eosinophilia was selected as key parameter since this feature is
strongly associated with allergy. Furthermore, the development of an airway eosinophilia in the present model
has been demonstrated to be strictly dependent on a functional Th2 response [26] (see additional file 1).
Analysis of the effect of IL-7 on Th1/Th2 polarization
PBMCs from 5 patients with seasonal allergic rhinitis were
purified as described above. 2.5 × 106 cells in 2 mL culture
medium (cells/mL) were stimulated with 100 μg/mL grass
or pollen extract in the presence or absence of 10 ng/mL
rhIL-7 (R&D systems Ltd, UK). The culture supernatants
were collected after 7 days. IL-5, IL-13 and IFNγ cytokines
were analyzed in the supernatants using human interleukin Quantikin ELISA kits from R&D systems according
to the manufacturer's protocol. IL-4 Quantikin HS kit was
used to for quantitative determination of human IL-4 concentrations in cell culture supernatants.
Statistical analysis
Paired comparisons were performed using the Wilcoxon
signed-rank test, while unpaired ones were performed
using the Mann-Whitney U-test. The Spearman rank correlation test was used to study correlations.
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